Michael Millenson
- Oncology top 0.5%
- Viral-associated cancers and disorders 17
- Lung Cancer Research Studies 9
- Cancer Treatment and Pharmacology 6
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 38
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 12
- Immunology top 2%
- Immune Cell Function and Interaction 5
- Neurology top 2%
- CNS Lymphoma Diagnosis and Treatment 10
-
- Lung Cancer Treatments and Mutations 16
- Co-authors
- Scott J. RodigLi ZhuAhmad HalwaniPhilippe ArmandDeepika CattryIvan BorrelloMargaret A. ShippStephen J. Schuster
- Partner nations
- United StatesItalyCanada
In The Last Decade
Michael Millenson
64 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 3.0k
- Pathology and Forensic Medicine 2.0k
- Genetics 747
- Immunology 1.4k
- Neurology 619
Countries citing papers authored by Michael Millenson
This map shows the geographic impact of Michael Millenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Millenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Millenson more than expected).
Fields of papers citing papers by Michael Millenson
This network shows the impact of papers produced by Michael Millenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Millenson. The network helps show where Michael Millenson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Millenson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 7 | |
| 2 | 2014 | 27 | |
| 3 | 2013 | 32 | |
| 4 | 2013 | 9 | |
| 5 | 2012 | 171 | |
| 6 | 2011 | 66 | |
| 7 | 2010 | 1 | |
| 8 | 2010 | 2 | |
| 9 | 2009 | 11 | |
| 10 | 2008 | 5 | |
| 11 | 2008 | 42 | |
| 12 | 2007 | 7 | |
| 13 | 2007 | 31 | |
| 14 | 2007 | 1 | |
| 15 | 2006 | 17 | |
| 16 | 2004 | 3 | |
| 17 | 2003 | 17 | |
| 18 | 2002 | 32 | |
| 19 | 2000 | 10 | |
| 20 | Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network. | 1996 | 6 |
About Michael Millenson
Michael Millenson is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 64 papers that have together received 4.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (38 papers), Viral-associated cancers and disorders (17 papers), Lung Cancer Treatments and Mutations (16 papers), Chronic Lymphocytic Leukemia Research (12 papers), CNS Lymphoma Diagnosis and Treatment (10 papers), Lung Cancer Research Studies (9 papers), Cancer Treatment and Pharmacology (6 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Oncology (3.0k citations), Pathology and Forensic Medicine (2.0k citations) and Genetics (747 citations). Michael Millenson has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Scott J. Rodig, Li Zhu, Ahmad Halwani, Philippe Armand, Deepika Cattry, Ivan Borrello, Margaret A. Shipp, Stephen J. Schuster, John M. Timmerman and Azra H. Ligon. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer, Journal of Thoracic Oncology and Journal of the National Comprehensive Cancer Network.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.